The Emergence and Evolution of the Multidimensional Organization

The article discusses multidimensional organizations and the evolution of complex organizations. The six characteristics of multidimensional organizations, disadvantages of the successful organizational structure that is categorized as a multidivisional, multi-unit or M-form, research by the Foundation for Management Studies which suggests that synergies across business divisions can be exploited by the M-form, a team approach to creating economic value, examples of multidimensional firms such as PricewaterhouseCoopers, and a comparison of various organization types including the matrix form are mentioned

Low-density star cluster formation: Discovery of a young faint fuzzy on the outskirts of the low-mass spiral galaxy NGC 247

The classical globular clusters found in all galaxy types have half-light radii of rh ~2-4 pc, which have been tied to formation in the dense cores of giant molecular clouds. Some old star clusters have larger sizes, and it is unclear if these represent a fundamentally different mode of low-density star cluster formation. We report the discovery of a rare, young \u27faint fuzzy\u27 star cluster, NGC 247-SC1, on the outskirts of the low-mass spiral galaxy NGC 247 in the nearby Sculptor group, and measure its radial velocity using Keck spectroscopy. We use Hubble Space Telescope imaging to measure the cluster half-light radius of rh ≃ 12 pc and a luminosity of LV ≃ 4 × 105Lθ. We produce a colour-magnitude diagram of cluster stars and compare to theoretical isochrones, finding an age of ≃300 Myr, a metallicity of [Z/H] ~-0.6 and an inferred mass of M∗ ≃ 9 × 104Mθ. The narrow width of blue-loop star magnitudes implies an age spread of ≲50 Myr, while no old red-giant branch stars are found, so SC1 is consistent with hosting a single stellar population, modulo several unexplained bright \u27red straggler\u27 stars. SC1 appears to be surrounded by tidal debris, at the end of an ∼2 kpc long stellar filament that also hosts two low-mass, low-density clusters of a similar age. We explore a link between the formation of these unusual clusters and an external perturbation of their host galaxy, illuminating a possible channel by which some clusters are born with large sizes

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection